Intravenous lacosamide in clinical practice-Results from an independent registry

Seizure

Volumn 39, Issue , 2016, Pages 5-9

  Lang, Nicolas ^a   Lange, Max ^b   Schmitt, Friedhelm C ^c   Bös, Monika ^d   Weber, Yvonne ^e   Evers, Stefan ^f   Burghaus, Lothar ^g   Kellinghaus, Christoph ^h   Schubert Bast, Susanne ⁱ   Bösel, Julian ⁱ   Lammers, Thorsten ^j   Sabolek, Michael ^k   Van Baalen, Andreas ^a   Dziewas, Rainer ^l   Kraft, Andrea ^m   Ruf, Susanne ⁿ   Stephani, Ulrich ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^d St Johannes Hospital   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f Department of Geriatrics   (Germany)

^g UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^h Andreas Bannowsky Ltd   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j Johanna Etienne Hospital   (Germany)

^k Neurology Specialist Hospital Dietenbronn   (Germany)

^l UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^m Hospital Martha Maria   (Germany)

ⁿ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

more..

Author keywords

Efficacy; Epilepsy; Lacosamide iv; Seizure; Status epilepticus; Tolerability

Indexed keywords

HARKOSERIDE; ACETAMIDE DERIVATIVE; ANTICONVULSIVE AGENT; LACOSAMIDE;

ADULT; ANTICONVULSANT THERAPY; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRONCHOPNEUMONIA; CARCINOMATOUS MENINGITIS; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPLETE HEART BLOCK; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; EPILEPSY; EPILEPTIC DISCHARGE; FEMALE; FOCAL EPILEPSY; GASTROINTESTINAL DISEASE; GENERALIZED EPILEPSY; HEART ARREST; HUMAN; INFECTION; INFESTATION; LIVER CIRRHOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MEMORY DISORDER; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT DISEASE; REVIEW; SEIZURE; THORAX DISEASE; VOMITING; ADOLESCENT; AGED; CHILD; GERMANY; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; OUTCOME ASSESSMENT; PRESCHOOL CHILD; REGISTER; SEIZURES; STATUS EPILEPTICUS; VERY ELDERLY; YOUNG ADULT;

ACETAMIDES; ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GERMANY; HUMANS; INFANT; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; SEIZURES; STATUS EPILEPTICUS; YOUNG ADULT;

EID: 84965126900     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2016.01.008     Document Type: Article

References (24)

1. E. Ben-Menachem, V. Biton, D. Jatuzis, B. Abou-Khalil, P. Doty, and G.D. Rudd Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures Epilepsia 48 7 2007 1308 1317
2. S. Chung, M.R. Sperling, V. Biton, G. Krauss, D. Hebert, G.D. Rudd, and et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial Epilepsia 51 6 2010 958 967
3. P. Halász, R. Kälviäinen, M. Mazurkiewicz-Beldzińska, F. Rosenow, P. Doty, D. Hebert, and et al. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial Epilepsia 50 3 2009 443 453
4. Kropeit D, Scharfenecker U, Schiltmeyer B, et al. Lacosamide has low potential for drug-drug interaction. Presented at the 59th Annual Meeting of the American Epilepsy Society; December 2, 2005. Abstract.
5. D. Jatuzis, V. Biton, E. Ben-Menachem, B. Abou-Khalil, P. Doty, and G.D. Rudd Evaluation of the effect of oral lacosamide on concomitant AED plasma concentrations in patients with partial seizures Epilepsia 46 Suppl 8 2005 170 Abstract
6. V. Biton, W.E. Rosenfeld, J. Whitesides, N.B. Fountain, N. Vaiciene, and G.D. Rudd Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures Epilepsia 49 3 2008 418 424
7. G. Krauss, E. Ben-Menachem, R. Mameniskiene, N. Vaiciene-Magistris, M. Brock, J.G. Whitesides, and et al. Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures Epilepsia 51 6 2010 951 957
8. H. Meierkord, P. Boon, B. Engelsen, K. Göcke, S. Shorvon, P. Tinuper, and et al. EFNS guideline on the management of status epilepticus in adults Eur J Neurol 17 3 2010 348 355
9. C. Kellinghaus, S. Berning, I. Immisch, J. Larch, F. Rosenow, A.O. Rossetti, and et al. Intravenous lacosamide for treatment of status epilepticus Acta Neurol Scand 123 2 2011 137 141
10. J.M. Albers, G. Möddel, R. Dittrich, C. Steidl, S. Suntrup, E.B. Ringelstein, and et al. Intravenous lacosamide - an effective add-on treatment of refractory status epilepticus Seizure 20 5 2011 428 430
11. J. Höfler, I. Unterberger, J. Dobesberger, G. Kuchukhidze, G. Walser, and E. Trinka Intravenous lacosamide in status epilepticus and seizure clusters Epilepsia 52 10 2011 e148 e152
12. L. Mnatsakanyan, J.M. Chung, E.I. Tsimerinov, and D.S. Eliashiv Intravenous Lacosamide in refractory nonconvulsive status epilepticus Seizure 21 3 2012 198 201
13. J. Miró, M. Toledo, E. Santamarina, A.C. Ricciardi, V. Villanueva, A. Pato, and et al. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study Seizure 22 1 2013 77 79
14. Rosenow, and et al. Status epilepticus im Erwachsenenalter Cif Weimar, H.C. Diener, Leitlinien für Diagnostik und Therapie in der Neurologie Eds 2012 Thieme Verlag Stuttgart
15. P. Doty, G.D. Rudd, T. Stoehr, and D. Thomas Lacosamide Neurotherapeutics 4 1 2007 145 148
16. B.K. Beyreuther, J. Freitag, C. Heers, N. Krebsfänger, U. Scharfenecker, and T. Stöhr Lacosamide: a review of preclinical properties CNS Drug Rev 13 1 2007 21 42
17. C.G. Wasterlain, T. Stöhr, and A. Matagne The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus Epilepsy Res 94 1-2 (March) 2011 10 17
18. C. Kellinghaus, S. Berning, and M. Besselmann Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy Epilepsy Behav 14 2 2009 429 431
19. C. Tilz, R. Resch, T. Hofer, and C. Eggers Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide Epilepsia 51 2 2010 316 317
20. H. Goodwin, H.E. Hinson, K.M. Shermock, N. Karanjia, and J.J. Levin 3rd The use of lacosamide in refractory status epilepticus Neurocrit Care 14 3 2011 348 353
21. E. Santamarina, M. Toledo, M. Sueiras, M. Raspall, N. Ailouti, E. Lainez, and et al. Usefulness of intravenous lacosamide in status epilepticus J Neurol 260 12 2013 3122 3128
22. B. Legros, C. Depondt, M. Levy-Nogueira, Ligot N, Mavroudakis N, G. Naeije, and et al. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses Neurocrit Care 20 3 2014 484 488
23. M. Garcés, V. Villanueva, J.A. Mauri, A. Suller, C. García, and F.J. López González Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study Epilepsy Behav 36 2014 144 152
24. V. Biton Lacosamide for the treatment of partial-onset seizures Expert Rev Neurother 12 6 2012 645 655